Stay updated on Pembrolizumab in Advanced Adrenocortical Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Advanced Adrenocortical Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Advanced Adrenocortical Carcinoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    - Revision: v3.5.5 replaces the previous Revision: v3.5.4 in the page's revision history, indicating the latest build of the page.
    Difference
    0.1%
    Check dated 2026-06-06T13:46:40.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    A new revision entry, v3.5.4, was added to the revision history, replacing the previous v3.5.3; this reflects an update to the page's documentation/metadata.
    Difference
    0.1%
    Check dated 2026-05-15T23:54:49.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The page’s revision/version indicator was updated from **v3.5.2** to **v3.5.3**, reflecting a change in the site’s interface or backend version rather than the underlying clinical trial information.
    Difference
    0.1%
    Check dated 2026-04-24T17:10:59.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T14:09:39.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Updates to the Study Record Dates (e.g., 2026-04-06; 2026-03-23) reflect maintenance of the page's history. The core trial information remains unchanged.
    Difference
    0.3%
    Check dated 2026-04-10T09:12:45.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    Added Adrenal cortex carcinoma as a visible keyword/context reference and linked a Genetics and Rare Diseases Information Center resource. This provides additional background context and a direct external reference related to the study topic.
    Difference
    0.2%
    Check dated 2026-04-03T06:08:00.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Advanced Adrenocortical Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Adrenocortical Carcinoma Clinical Trial page.